CREBBP and lymphoma: To directly address this concern and to further assess the effect of cPAF on the acetylation of p21, we used a genetically engineered lymphoma line cell, OCI-Ly7, which was constructed with a partial deletion in the HAT domain on CBP (See Material and Methods).